A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease
Clinical trial NCT03100149 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03100149
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-27
- Primary completion
- 2019-11-27
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.